Sign In
4 Sep 2014 13:50
Biofrontera AG
("Biofrontera" or the "Company")
Director Dealing
Biofrontera AG (AIM:B8F), the European biopharmaceutical company, announces that on 4 September 2014 Thomas Schaffer, the Chief Financial Officer of the Company, purchased 2,000 ordinary shares of no par value in the capital of the Company ("Ordinary Shares") at a price of EUR 2.320 per Ordinary Share. Subsequent to this transaction Mr Schaffer has a beneficial interest in 10,088 Ordinary Shares representing 0.045% of the issued ordinary share capital of the Company.
For further information, please contact:
Biofrontera AG
|
| ||
Prof. Hermann Lübbert, Chief Executive Officer Thomas Schaffer , Chief Financial Officer | Tel: + 49 (0) 214 - 87632 - 22
| ||
|
| ||
finnCap (Nomad and Broker) |
| ||
Geoff Nash / Christopher Raggett (Corporate Finance) | Tel: 020 7220 0500 | ||
Steven Norcross(Corporate Broking) |
| ||
|
| ||
Investor Relations |
| ||
Seton Services |
| ||
Toni Vallen | Tel: 020 7603 6797 | ||
|
| ||
Financial PR Gable Communications |
| ||
John Bick | Tel: 020 7193 7463 |
B8F.L (B8F)
Follow the stocks
